International Biotechnology Trust PLC Seagen Inc. Transaction History

International Biotechnology Trust PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 18, 2023	BUY	$127.59 - $203.08 $4.34 Million - $6.9 Million	34,000 Added 20.46%	200,200 $40.5 Million
Q3 2022 Nov 08, 2022	BUY	$135.27 - $180.11 $20.9 Million - $27.8 Million	154,593 Added 1331.89%	166,200 $22.7 Million
Q2 2022 Aug 16, 2022	SELL	$108.81 - $179.33 $7.03 Million - $11.6 Million	-64,593 Reduced 84.77%	11,607 $65.6 Million
Q1 2022 May 20, 2022	SELL	$119.61 - $157.85 $4.43 Million - $5.84 Million	-37,000 Reduced 32.69%	76,200 $11 Million
Q4 2021 Feb 15, 2022	BUY	$142.57 - $190.86 $498,995 - $668,010	3,500 Added 3.19%	113,200 $17.5 Million
Q3 2021 Nov 12, 2021	SELL	$142.45 - $169.82 $5.03 Million - $5.99 Million	-35,300 Reduced 24.34%	109,700 $18.6 Million
Q2 2021 Aug 11, 2021	BUY	$135.08 - $161.1 $1.62 Million - $1.93 Million	12,000 Added 9.02%	145,000 $22.9 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $9.28 Million - $12.9 Million	67,500 Added 103.05%	133,000 $18.5 Million
Q4 2020 Feb 19, 2021	BUY	$164.63 - $211.93 $10.8 Million - $13.9 Million	65,500 New	65,500 $11.5 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.